Evidence map›Paper›PMID 40331266›Full record

ReviewTransactions of the Royal Society of Tropical Medicine and Hygiene2025

Cutaneous leishmaniasis in Afghanistan.

Bilal Ahmad Rahimi, Mohammad Amin Ghatee, Muhammad Naeem Habib, Khushhal Farooqi, Koert Ritmeijer, Huma Syed Hussain, M Asim Beg, Walter R Taylor

Abstract readReview
In one paragraph

Review in Transactions of the Royal Society of Tropical Medicine and Hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Infection Without Borders.Journal of paediatrics and child health · 2026
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bilal Ahmad RahimiDepartment of Pediatrics, Faculty of Medicine, Kandahar University, Kandahar 3801, Afghanistan.ORCID 0000-0002-6630-5742
Mohammad Amin GhateeDepartment of Medical Micriobiology, Professor Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz 71348-14336, Iran.
Muhammad Naeem HabibDepartment of Malaria, National Malaria & Other Vector Borne Diseases Program, Ministry of Public Health, Kabul 1001, Afghanistan.
Khushhal FarooqiDepartment of Pediatrics, Faculty of Medicine, Kandahar University, Kandahar 3801, Afghanistan.
Koert RitmeijerMédecins Sans Frontières, Amsterdam 14 1018, the Netherlands.
Huma Syed HussainDepartment of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi 74800, Pakistan.
M Asim BegDepartment of Pathology and Laboratory Medicine, Aga Khan University Hospital, Karachi 74800, Pakistan.
Walter R TaylorMahidol Oxford Tropical Medicine Clinical Research Unit, Bangkok 10400, Thailand.

Funding

Wellcome TrustWellcome Trust 220211
6 · The paper itself

Abstract

Old World cutaneous leishmaniasis (OWCL) is a sand fly-transmitted skin infection caused by Leishmania species that extends from West Africa to China. Afghanistan probably has the highest burden of OWCL and is home chiefly to Leishmania  tropica and Leishmania  major, which cause anthroponotic and zoonotic CL, respectively. Although data on the species distribution in Afghanistan are patchy, L. tropica predominates over L. major, reflecting its concentration in large cities. CL prevalence in Afghanistan increases with increasing age to peak at 5-10 y, depending on the local epidemiology. Clinically, there is a spectrum of lesions common to both main species with nodules, ulcerated nodules and papules accounting for the majority (50-80%) of lesions at presentation. When healed, CL lesions leave pale scars that often have deleterious psychosocial effects. Leishmania control involves vector control and treating patients, but these are severely challenged by decades of war and disruption to the health system. In the public sector, only injectable antimonials, sodium stibogluconate or meglumine antimoniate, are available and, anecdotally, efficacy remains high. Few clinical trials have been conducted in Afghanistan and data support antimonial efficacy; small clinical series suggest good efficacy of oral miltefosine against the two main species. Herein, we focus our review on the epidemiological and clinical aspects of CL in Afghanistan and suggest avenues of future research.

Indexed as

Antiprotozoal AgentsLeishmaniasis, CutaneousAfghanistanAnimalsAntimony Sodium GluconateFemaleHumansLeishmania majorLeishmania tropicaMaleMeglumineMeglumine AntimoniatePrevalenceAntimony Sodium GluconateAntiprotozoal AgentsMeglumineMeglumine AntimoniateAfghanistancutaneousKandaharleishmaniasistreatment

Identifiers

PMID40331266
PMCPMC12342938

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.